Since the past decades, more lung cancer patients have been experiencing lasting benefits
from immunotherapy. It is imperative to accurately and intelligently select appropriate …

Simple Summary Tumor-infiltrating lymphocytes (TILs) are immune cells that can be
involved in the anti-tumor response and are presently viewed as a promising, inexpensive …

Artificial intelligence (AI) in oncology is advancing beyond algorithm development to
integration into clinical practice. This review describes the current state of the field, with a …

Artificial intelligence (AI) can acquire characteristics that are not yet known to humans
through extensive learning, enabling to handle large amounts of pathology image data …

Background Recent advances in digital pathology have enabled accurate and standardised
enumeration of tumour-infiltrating lymphocytes (TILs). Here, we aim to evaluate TILs as a …

Purpose: We sought to identify features of patients with advanced non–small cell lung
cancer (NSCLC) who achieve long-term response (LTR) to immune checkpoint inhibitors …

Lung cancer has the highest mortality rate among all cancer types, resulting in over 1.8
million deaths annually. Immunotherapy utilizing immune checkpoint inhibitors (ICIs) has …

Obesity is a risk factor for cancer, but whether obesity is linked to specific genomic subtypes
of cancer is unknown. We examined the relationship between obesity and tumor genotype in …

The integration of cancer biomarkers into oncology has revolutionized cancer treatment,
yielding remarkable advancements in cancer therapeutics and the prognosis of cancer …

Despite the advantages offered by personalized treatments, there is presently no way to
predict response to chemoradiotherapy in patients with non-small cell lung cancer (NSCLC) …